105 related articles for article (PubMed ID: 24647337)
1. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X
Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817
[TBL] [Abstract][Full Text] [Related]
3. Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.
Huang H; Chen X; Li D; He Y; Li Y; Du Z; Zhang K; DiPaola R; Goodin S; Zheng X
PLoS One; 2015; 10(12):e0144293. PubMed ID: 26630272
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
He Y; Huang H; Farischon C; Li D; Du Z; Zhang K; Zheng X; Goodin S
Oncol Rep; 2017 Feb; 37(2):953-960. PubMed ID: 28075470
[TBL] [Abstract][Full Text] [Related]
5. Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells.
Wei X; Zhou D; Wang H; Ding N; Cui XX; Wang H; Verano M; Zhang K; Conney AH; Zheng X; DU ZY
Anticancer Res; 2013 Apr; 33(4):1343-50. PubMed ID: 23564771
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
Zheng X; Cui XX; Gao Z; Zhao Y; Lin Y; Shih WJ; Huang MT; Liu Y; Rabson A; Reddy B; Yang CS; Conney AH
Cancer Prev Res (Phila); 2010 Jan; 3(1):114-24. PubMed ID: 20051379
[TBL] [Abstract][Full Text] [Related]
10. Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Zhao SQ; DU ZY; Zheng XI; Zhang K
Oncol Lett; 2016 Jun; 11(6):4160-4166. PubMed ID: 27313760
[TBL] [Abstract][Full Text] [Related]
11. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.
Li W; Su ZY; Guo Y; Zhang C; Wu R; Gao L; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2018 Feb; 31(2):88-96. PubMed ID: 29228771
[TBL] [Abstract][Full Text] [Related]
13. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.
Guo H; Xu YM; Ye ZQ; Yu JH; Hu XY
Pharmazie; 2013 Jun; 68(6):431-4. PubMed ID: 23875250
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-kappaB by (E)3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (BAY11-7082; BAY) is associated with enhanced 12-O-tetradecanoylphorbol-13-acetate-induced growth suppression and apoptosis in human prostate cancer PC-3 cells.
Zheng X; Chang RL; Cui XX; Avila G; Huang MT; Liu Y; Kong AN; Rabson AB; Conney AH
Int J Oncol; 2008 Jan; 32(1):257-64. PubMed ID: 18097566
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
17. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]